Wang Bo, Zhao Chang-Ping, Song Lian-Xin, Zhu Lian
Department of Orthopedic Trauma Centre, 3rd Hospital of Hebei Medical University, No. 139 ZiQiang Road, Qiaoxi District, Shijiazhuang, 050051, China.
J Orthop Surg Res. 2018 Oct 22;13(1):264. doi: 10.1186/s13018-018-0952-5.
This meta-analysis was aimed to explore the overall safety and efficacy of balloon kyphoplasty versus percutaneous vertebroplasty for osteoporotic vertebral compression fracture (OVCF) based on qualified studies.
By searching multiple databases and sources, including PubMed, Cochrane, and Embase by the index words updated to January 2018, qualified studies were identified and relevant literature sources were also searched. The qualified studies included randomized controlled trials, prospective or retrospective comparative studies, and cohort studies. The meta-analysis was performed including mean difference (MD) or relative risk (RR) and 95% confidence interval (95% CI) to analyze the main outcomes.
A total of 16 studies were included in the meta-analysis to explore the safety and efficacy of kyphoplasty versus vertebroplasty for the treatment of OVCF. The results indicated that kyphoplasty significantly decreased the kyphotic wedge angle (SMD, 0.98; 95% CI 0.40-1.57), increased the postoperative vertebral body height (SMD, - 1.27; 95% CI - 1.86 to - 0.67), and decreased the risk of cement leakage (RR, 0.62; 95% CI 0.47-0.80) in comparison with vertebroplasty. However, there was no statistical difference in visual analog scale (VAS) scores (WMD, 0.04; 95% CI - 0.28-0.36) and Oswestry Disability Index (ODI) scores (WMD, - 1.30; 95% CI - 3.34-0.74) between the two groups.
Kyphoplasty contributes especially to decreasing the mean difference of kyphotic wedge angle and risk of cement leakage and increasing the vertebral body height when compared with vertebroplasty. But radiographic differences did not significantly influence the clinical results (no significant difference was observed in VAS scores and ODI scores between the two groups); thus, kyphoplasty and vertebroplasty are equally effective in the clinical outcomes of OVCF. In addition, more high-quality multi-center RCTs with a larger sample size and longer follow-up are warranted to confirm the current findings.
本荟萃分析旨在基于合格研究探讨球囊后凸成形术与经皮椎体成形术治疗骨质疏松性椎体压缩骨折(OVCF)的总体安全性和有效性。
通过检索多个数据库和来源,包括截至2018年1月更新索引词的PubMed、Cochrane和Embase,确定合格研究并检索相关文献来源。合格研究包括随机对照试验、前瞻性或回顾性比较研究以及队列研究。进行荟萃分析,包括均值差(MD)或相对风险(RR)以及95%置信区间(95%CI),以分析主要结局。
共有16项研究纳入荟萃分析,以探讨后凸成形术与椎体成形术治疗OVCF的安全性和有效性。结果表明,与椎体成形术相比,后凸成形术显著降低了后凸楔角(标准化均值差,0.98;95%CI 0.40 - 1.57),增加了术后椎体高度(标准化均值差,-1.27;95%CI -1.86至-0.67),并降低了骨水泥渗漏风险(RR,0.62;95%CI 0.47 - 0.80)。然而,两组之间视觉模拟评分(VAS)(加权均值差,0.04;95%CI -0.28 - 0.36)和Oswestry功能障碍指数(ODI)评分(加权均值差,-1.30;95%CI -3.34 - 0.74)无统计学差异。
与椎体成形术相比,后凸成形术尤其有助于降低后凸楔角的均值差和骨水泥渗漏风险,并增加椎体高度。但影像学差异并未显著影响临床结果(两组之间VAS评分和ODI评分无显著差异);因此,后凸成形术和椎体成形术在OVCF的临床结局方面同样有效。此外,需要更多高质量、大样本量且随访时间更长的多中心随机对照试验来证实当前研究结果。